Advertisement

Topics

Elanix Biotechnologies AG: CRIMINAL CHARGES HAVE BEEN FILED AGAINST THE FORMER CEO THOMAS J. SVOBODA ALONG WITH FURTHER TWO SUSPECTED ACCOMPLICES

03:26 EDT 13 May 2019 | EQS Group

Elanix Biotechnologies AG / Key word(s): Miscellaneous
Elanix Biotechnologies AG: CRIMINAL CHARGES HAVE BEEN FILED AGAINST THE FORMER CEO THOMAS J. SVOBODA ALONG WITH FURTHER TWO SUSPECTED ACCOMPLICES

13-May-2019 / 07:26 CET/CEST
Disclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No 596/2014, transmitted by DGAP - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.


Ad Hoc English, 13 May 2019

ELANIX BIOTECHNOLOGIES AG: CRIMINAL CHARGES HAVE BEEN FILED AGAINST THE FORMER CEO THOMAS J. SVOBODA ALONG WITH FURTHER TWO SUSPECTED ACCOMPLICES. FURTHERMORE, PROFESSOR LAURENT-APPLEGATE, FOUNDER AND INTERIM-CEO, ANNOUNCES TRANSFER OF SHARES IN ELANIX BIOTECHNOLOGIES AG.

Frankfurt, 13 May 2019 - Elanix Biotechnologies AG ("Elanix" or the "Company") has filed criminal charges against the former CEO Thomas J. Svoboda. Criminal charges will also be filed against two further accomplices of Mr. Svoboda.

Furthermore, Professor Laurent-Applegate, founder and Interim-CEO of Elanix, has announced that today, she has transferred a total of 1,038,609 shares of Elanix to Anja Silling (Chairman Of The Supervisory Board). This is equivalent to approximately 12.85 per cent of the Company's issued share capital. The purchase price is EUR 1.00 which is significantly below the current market price.

Lee Ann Laurent-Applegate

CEO

13-May-2019 CET/CEST The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.dgap.de


show this

Original Article: Elanix Biotechnologies AG: CRIMINAL CHARGES HAVE BEEN FILED AGAINST THE FORMER CEO THOMAS J. SVOBODA ALONG WITH FURTHER TWO SUSPECTED ACCOMPLICES

NEXT ARTICLE

More From BioPortfolio on "Elanix Biotechnologies AG: CRIMINAL CHARGES HAVE BEEN FILED AGAINST THE FORMER CEO THOMAS J. SVOBODA ALONG WITH FURTHER TWO SUSPECTED ACCOMPLICES"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Biotechnology
Antibodies Antisense Assays Biochips Bioinformatics Biological Therapy Biomarkers Biomaterials Bioscience Cell Culture Cloning Cytokine Diagnostics Dna Extraction Dna Sequencing Dna Transform...